Loading news...
Eli Lilly (LLY) concluded the recent trading session at $1, signifying a +1.64% move from its prior day's close.
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., in an effort to speed up the use of AI in the pharmaceutical industry. Denny Fish, portfolio manager on the Global Technology and Innovation Team at Janus Henderson Investors, joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.
NVIDIA plans to invest $1 billion over five years in a new laboratory with Eli Lilly and Company, aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Heres what Eli Lilly CFO Lucas Montarce had to say about the partnership.
Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) and Eli Lilly and Co (NYSE:LLY) have announced the creation of a new AI-focused co-innovation lab aimed at accelerating drug discovery and development. The lab will combine Lilly's expertise in medicine discovery, development, and manufacturing with Nvidia's AI and computing capabilities, the companies announced on Monday.
One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery.
Eli Lilly Chief Financial Officer Lucas Montarce says the company's weight-loss pill is on track to be approved in the US as early as the second quarter of this year. He speaks to Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco.
Eli Lilly said on Monday it is confident about the supplies of its weight-loss pill orforglipron ahead of its anticipated U.S. approval in the coming months.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Jessica Nix has more on "Bloomberg Open Interest.
Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area over five years which will use Nvidia's newest generation Vera Rubin AI chips, the firms said on Monday.
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather and then heading higher.
Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) and Eli Lilly and Co (NYSE:LLY) have announced the creation of a new AI-focused co-innovation lab aimed at accelerating...
Phillips Financial Management LLC raised its holdings in Eli Lilly and Company (NYSE: LLY) by 138.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,100 shares of the company's stock after purchasing an additional 1,799 shares during the quarter. Phillips
Legacy Trust lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 119.1% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,244 shares of the company's stock after purchasing an additional 1,220 shares during the quarter. Legacy
Trilogy Capital Inc. lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 11.9% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,686 shares of the company's stock after buying an additional 499 shares during the period. Trilogy Capital
Sonoma Allocations LLC bought a new position in Eli Lilly and Company (NYSE: LLY) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,274 shares of the company's stock, valued at approximately $1,045,000. Other hedge funds have also modified their holdings of
Parnassus Investments LLC reduced its holdings in Eli Lilly and Company (NYSE: LLY) by 25.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 628,280 shares of the company's stock after selling 219,296 shares during the quarter. Parnassus Investments LLC owned approximately 0.07%
Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.
Associated Banc Corp grew its stake in Eli Lilly and Company (NYSE: LLY) by 2.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,638 shares of the company's stock after buying an additional 1,272 shares during